Effects of Smilax China L. extracts on Hyperuricemia chicken model via inhibiting xanthine oxidase activity

• Published in: Poultry science 2024-08, Vol.103 (8), p.103887, Article 103887
• Main Authors: Yan, Mingen, Zheng, Xiaoman, Lin, Yongshi, Zheng, Xirui, Xi, Kailun, Gao, Yun, Wang, Huiting, Li, Yaoxing, Liu, Cui
• Format: Article
• Language: English
• Subjects: hyperuricemia; kidney injury; METABOLISM AND NUTRITION; Smilax China L. extract; xanthine oxidase inhibition
• ISSN: 0032-5791; 1525-3171; 1525-3171
• DOI: 10.1016/j.psj.2024.103887

Hyperuricemia (HUA) is a metabolic disorder caused by excessive production of uric acid (UA) or impaired uric acid metabolism. Smilax China L. has a wide range of pharmacological activities such as immunomodulatory, anti-inflammatory, and antioxidant. Its roots and rhizomes have been widely used for the treatment of HUA. However, its mechanisms for treating HUA and reducing renal impairment have not been fully elucidated. In the present study, we evaluated the effect of Smilax China L. extract (SC) on UA metabolism and further explored its mechanism of action by feeding a high-calcium and high-protein diet to chickens to induce a model of HUA in chickens. SC significantly reduced serum UA levels and improved renal function in hyperuricemic chickens. Meanwhile, SC was able to inhibit the activity of xanthine oxidase (XOD) in vivo and in vitro, reducing the production of uric acid. In addition, SC was able to increase the expression of Breast Cancer Resistance Protein (BCRP) in the kidney and ileum and increase uric acid excretion. Therefore, our results suggest that SC may be a candidate for anti-hyperuricemia.